Cargando…
RNA blood levels of osteopontin splice variants are cancer markers
PURPOSE: Despite a sizeable and continuously growing literature on osteopontin and cancer the molecule has not yet found entry into clinical diagnostics. Our identification of spliced variants that are more specific for cancer than the full-length transcript has opened new possibilities for reaching...
Autores principales: | Hartung, Franz, Weber, Georg F |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing AG
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3608879/ https://www.ncbi.nlm.nih.gov/pubmed/23543917 http://dx.doi.org/10.1186/2193-1801-2-110 |
Ejemplares similares
-
Meta-analysis of Osteopontin splice variants in cancer
por: An, Yu, et al.
Publicado: (2023) -
Osteopontin splice variants are differential predictors of breast cancer treatment responses
por: Zduniak, Krzysztof, et al.
Publicado: (2016) -
Breast cancer risk in papilloma patients: Osteopontin splice variants indicate prognosis
por: Ziółkowski, Piotr, et al.
Publicado: (2022) -
Breast cancer risk in premalignant lesions: osteopontin splice variants indicate prognosis
por: Walaszek, Kinga, et al.
Publicado: (2018) -
Prognostic impact of mRNA levels of osteopontin splice variants in soft tissue sarcoma patients
por: Hahnel, Antje, et al.
Publicado: (2012)